Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer’s Disease: A Blinded Validation Study

202053 citationsJournal Article

Authors

MDS-OAβ to measure plasma Aβ oligomerization is a valuable blood-based biomarker for clinical diagnosis of AD, with high sensitivity and specificity.

Published in: Journal of Alzheimer s Disease

Volume 75, Issue 2, pp. 493-499

Field-Weighted Citation Impact: 3.97